Elkfork Partners’s Core Laboratories CLB Stock Holding History

Elkfork Partners’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$406K	Buy	8,708 +1,652	+23%	+$76.8K	0.01%	646
2019 Q2	$369K	Hold	7,056	–	–	0.01%	674
2019 Q1	$486K	Hold	7,056	–	–	0.01%	569
2018 Q4	$421K	Hold	7,056	–	–	0.01%	565
2018 Q3	$817K	Buy	7,056 +952	+16%	+$107K	0.02%	436
2018 Q2	$770K	Sell	6,104 -1,148	-16%	-$140K	0.02%	409
2018 Q1	$785K	Sell	7,252 -2,660	-27%	-$294K	0.02%	397
2017 Q4	$1.09M	Sell	9,912 -3,164	-24%	-$316K	0.03%	346
2017 Q3	$1.29M	Buy	13,076 +4,256	+48%	+$413K	0.04%	294
2017 Q2	$893K	Sell	8,820 -2,968	-25%	-$320K	0.03%	347
2017 Q1	$1.36M	Hold	11,788	–	–	0.04%	284
2016 Q4	$1.42M	Buy	+11,788	New	+$1.31M	0.05%	264

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Elkfork Partners's CLB Position: Q3 2019 in Review

Elkfork Partners increased its Core Laboratories (CLB) stake by 23% in Q3 2019, buying an estimated $76.8K and bringing the position to 8,708 shares worth $406K. The position accounts for 0.01% of the portfolio, ranked #646.

Elkfork Partners first reported a position in CLB in Q4 2016 and has held it in 12 quarters since. The position peaked at $1.42M in Q4 2016. 274 funds tracked by Wall St. Rank hold CLB as of Q3 2019.

Elkfork Partners held 8,708 shares of Core Laboratories worth $406K as of Q3 2019.
Elkfork Partners bought 1,652 Core Laboratories shares in Q3 2019, an estimated $76.8K.
Core Laboratories made up 0.01% of Elkfork Partners's portfolio in Q3 2019, its #646 holding.
Elkfork Partners first reported a position in Core Laboratories in Q4 2016 and has held it in 12 quarters since.
Elkfork Partners's Core Laboratories position peaked at $1.42M in Q4 2016.
274 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.